Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Clinical and Experimental Nephrology
Published in: Clinical and Experimental Nephrology 6/2013

01-12-2013 | Original Article

Factors associated with the incidence of dialysis

Authors: Satoshi Ogata, Shinichi Nishi, Kenji Wakai, Kunitoshi Iseki, Yoshiharu Tsubakihara

Published in: Clinical and Experimental Nephrology | Issue 6/2013

Login to get access

Abstract

Background

There are regional differences in the incidence of dialysis, but few studies have investigated the reasons for such differences.

Methods

We stratified 81 factors by gender for each of the 47 prefectures in Japan using the Japanese Society for Dialysis Therapy database of 102,011 patients who started chronic dialysis during 2004–2006.

Results

The age-adjusted average annual incidence of dialysis was 265.6 ± 38.9 per million population. Among the 81 factors tested, 30 showed significant correlations with the incidence of dialysis among males, and 36 among females by univariate regression analysis. Among those factors, multivariate regression analysis showed that the average duration of hospitalization, the mortality rate from malignancy, a history of leg amputation, and duration of sunshine were extracted as determinants of the incidents of dialysis among males, and a history of acute myocardial infarction, mortality rate from lifestyle-related diseases, vitamin C intake, mortality rate from malignancy, amount of family saving, number of dialysis specialists, birth rate, days of snow, potatoes intake, average annual temperature, average duration of hospitalization, protein intake, and mortality rate from cerebrovascular disease were extracted among females.

Conclusion

Many environmental factors were correlated with regional differences in the incidence of dialysis.
Literature
1.
Collins A, Foley R, Herzog C, Chavers B, Gilbertson D, Ishani A, et al. Excerpts from the United States renal data system 2009 annual data report: atlas of end-stage renal disease in the United States. Am J Kidney Dis. 2010;55(Suppl 1):S1–417.PubMedCentral
2.
Usami T, Koyama K, Takeuchi O, Morozumi K, Kimura G. Regional variations in the incidence of end-stage renal failure in Japan. JAMA. 2000;284:2622–4.PubMedCrossRef
3.
Lameire N, Biesen WV, Vanholder R. Initiation of dialysis—is the problem solved by NECOSAD? Nephrol Dial Transplant. 2002;17:1550–2.PubMedCrossRef
4.
Fan ZJ, Lackland DT, Lipsitz SR, Nicholas JS, Egan BM, Tim Garvey W, et al. Geographical patterns of end-stage renal disease incidence and risk factors in rural and urban areas of South Carolina. Health Place. 2007;13:179–87.PubMedCrossRef
5.
Caskey FJ, Schober-Halstenberg HJ, Roderick PJ, Edenharter G, Ansell D, Frei U, et al. Exploring the differences in epidemiology of treated ESRD between Germany and England and Wales. Am J Kidney Dis. 2006;47:445–54.PubMedCrossRef
6.
Usami T, Nakao N, Fukuda M, Takeuchi O, Kamiya Y, Yoshida A, et al. Maps of end-stage renal disease and amounts of angiotensin-converting enzyme inhibitors prescribed in Japan. Kidney Int. 2003;64:1445–9.PubMedCrossRef
7.
Furumatsu Y, Nagasawa Y, Hamano T, Iwatani H, Ito K, Shoji T, et al. Integrated therapies including erythropoietin decrease the incidence of dialysis: lessons from mapping the incidence of end-stage renal disease in Japan. Nephrol Dial Transplant. 2008;23:984–90.PubMedCrossRef
8.
Ogata S, Yorioka N, Gilbertson DT, Chen SC, Foley RN, Collins AJ. Genetic and environmental effects and characteristics of Japanese end-stage renal disease patients. Hemodial Int. 2009;13(Suppl 1):S8–12.PubMedCrossRef
9.
Ogata S, Yorioka N. Environmental factors influencing the survival of chronic dialysis patients. Clin Exp Nephrol. 2011;15:405–9.PubMedCrossRef
10.
Ogata S. Nutritional factors including the incidence of new dialysis due to diabetes mellitus in each prefecture of Japan. Nippon Jinzo Gakkai Shi. 2010;52:934–38 (in Japanese).
11.
Patient Registration Committee. In: Tsubakihara Y, editor. An overview of regular dialysis treatment in Japan as of Dec 31, 2009 CD-ROM. Tokyo, Japan: Japanese society for dialysis therapy, 2010.
12.
Japan Statistics Bureau. Statistical observations of Prefectures 2008. Tokyo, Japan: statistical association, 2008;1–195.
13.
14.
The Japanese Society for Dialysis Therapy. The member list of dialysis institutes of the Japanese society for dialysis therapy. Tokyo, Japan: Igaku Tosho Shuppan, 2006.
15.
16.
17.
Tomonari T, Fukuda M, Miura T, Mizuno M, Wakamatsu TY, Ichikawa T, et al. Is salt intake an independent risk factor of stroke mortality? Demographic analysis by regions in Japan. J Am Soc Hypertens. 2011;5:456–62.PubMedCrossRef
18.
Traxer O, Huel B, Poindexter J, Pak CY, Pearle MS. Effect of ascorbic acid consumption on urinary stone risk factors. J Urol. 2003;170(2 Pt 1):397–401.PubMedCrossRef
19.
Rodriguez-Iturbe B, Herrera J, Garcia R. Relationship between glomerular filtration rate and renal blood flow at different levels of protein-induced hyperfiltration in man. Clin Sci (Lond). 1988;74:11–5.PubMed
Metadata
Title
Factors associated with the incidence of dialysis
Authors
Satoshi Ogata
Shinichi Nishi
Kenji Wakai
Kunitoshi Iseki
Yoshiharu Tsubakihara
Publication date
01-12-2013
Publisher
Springer Japan
Published in
Clinical and Experimental Nephrology / Issue 6/2013
Print ISSN: 1342-1751
Electronic ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-013-0786-8

Other articles of this Issue 6/2013

Clinical and Experimental Nephrology 6/2013 Go to the issue

Review Article

Vasopressin and the regulation of aquaporin-2

Original Article

The intercalated cells of the mouse kidney OMCDis are the target of the vasopressin V1a receptor axis for urinary acidification

Original Article

Reduced podocin expression in minimal change disease and focal segmental glomerulosclerosis is related to the level of proteinuria

Original Article

CCL2/CCR2 augments the production of transforming growth factor-beta1, type 1 collagen and CCL2 by human CD45-/collagen 1-positive cells under high glucose concentrations

Original Article

Polymorphism in the human matrix Gla protein gene is associated with the progression of vascular calcification in maintenance hemodialysis patients

Original Article

The effects of tolvaptan on patients with severe chronic kidney disease complicated by congestive heart failure
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits